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The efﬁcient processing of human immunodeﬁciency virus type 1 Gag–Pol requires not only prote-
ase activity but also speciﬁc reverse transcriptase (RT) and integrase sequences. However, the critical
amino acid residues of the HIV-1 Pol gene involved in protease-mediated Gag–Pol processing have
not been precisely deﬁned. Here, we found that the substitution of Thr-128 or Tyr-146 with Ala
markedly impaired the proteolytic processing of the MA/CA, p66/p51 and RT/IN sites but did not
affect the normal processing of other sites. Moreover, a Thr-128 or Tyr-146 mutation in RT abolished
RT dimerization in vitro. These results suggest that Thr-128 and Tyr-146 within the RT region play
important roles in protease-mediated Gag–Pol processing.
Structured summary of protein interactions:
RT and RT physically interact by cross-linking study (View interaction: 1, 2, 3).
CK2 alpha phosphorylates RT by protein kinase assay (View interaction).
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction theC-terminalRNaseHdomain. RT–RT interactionsmayplay impor-The human immunodeﬁciency virus type 1 (HIV-1) Gag–Pol is
normally translated by a 1 ribosomal frameshift event occurring
at a frequency of approximately 5% duringGag translation, resulting
in a 1:20 ratio of synthesized Gag–Pol to Pr55-Gag [1]. The incorpo-
ration of Gag–Pol into virus particles requires its interaction with
Pr55-Gag [2]. The processing of Gag–Pol is accomplished by viral
protease activation during Gag–Pol/Gag–Pol interactions or Gag–
Pol multimerization [3]. The proteolytic processing of Gag follows
a sequential cascade of events that is kinetically controlled by differ-
ential rates of processing at each of the ﬁve cleavage sites in Gag
[4,5]. Protease-mediated Gag–Pol processing requires the protease
as well as domains upstream or downstream of the protease region,
such as the reverse transcriptase (RT) and integrase (IN) domains.
Mutants with an IN-domain deletion form markedly impaired viral
particles due to the impairment of normal protease activity [6].
Mature HIV-1 RT is a heterodimer with two subunits, p66 and p51.
The p51 subunit is derived from p66 by the proteolytic removal ofchemical Societies. Published by E
virus type 1; RT, reverse
propionate); PR, protease
of Life and Environmental
udanuma, Narashino, Chiba
.jp (H. Nishitsuji), hiroshi.tant roles inprotease activationbypromotingGag–Polmultimeriza-
tion. RT inhibitors enhance RT dimerization in vitro, resulting in
increased protease-speciﬁc cleavage of Pr55-Gag and Gag–Pol [7].
However, the deletion of the RT region leads to a marked reduction
in protease activation andparticlematuration [8]. The critical amino
acid residues of the HIV-1 RT that contribute to protease-mediated
Gag–Pol processing are not yet known.
In this study, we identiﬁed the HIV-1 RT amino acid residues
critical for Gag–Pol processing through the analysis of RT phos-
phorylation. The substitution of Thr-128 and Tyr-146 with Ala se-
verely impaired viral replication, due to defects in proteolytic
processing at the MA/CA, p66/p51, and RT/IN sites.2. Materials and methods
2.1. Plasmids
Details of the plasmid constructs used in this study are provided
in the Supplementary materials and methods.
2.2. Virus infection
For infection, 293T cells were co-transfected with 0.1 lg of
pMD.G-VSV-G and 0.1 lg of pNL43lucDenv or pNL43lucDenvlsevier B.V. All rights reserved.
H. Nishitsuji et al. / FEBS Letters 585 (2011) 3372–3377 3373containing an RT mutation of interest. At 48 h post-transfection,
the culture supernatants were harvested and ﬁltered through
0.45-lm ﬁlters. 293T cells were infected with pseudotyped viruses
(corresponding to 20 ng of p24). At 24 h postinfection, the cells
were harvested and lysed with 300 ll of cell-lysis buffer. An ali-
quot (10 ll) of each lysate was then subjected to a luciferase assay.2.3. Preparation of virions
Details are given in the Supplementary materials and methods.
2.4. Preparation of anti-RT sera
Details of anti-RT sera used in this study are given in the Sup-
plementary materials and methods.
2.5. Crosslinking
Crosslinking was performed as previously described [9].
2.6. Phosphorylation assay
Details are given in the Supplementary materials and methods.3. Results
3.1. Infectivity of RT-mutant viruses
Recent studies have indicated that the phosphorylation of HIV-1 RT
might play an important role inHIV-1 replication [10–11]. To evaluate
the role of the putatively phosphorylated RT, we predicted the phos-
phorylation site(s) of RT using the Scansite 2.0 program [12] and gen-
erated single-amino-acid Ala substitutions for the Ser, Thr, and Tyr
residues that are conserved among HIV-1 and simian immunodeﬁ-
ciency virus strains. We examined the effect of eachmutation on viral
replication using a single-round infection system (Fig. 1A). In this
study, infectionwith theS156Amutant led to slightlydiminished lucif-
erase activity (approximately 75%of theWT level). Similarly, the single
amino acid substitutions of Thr to Ala at position 27 (T27A) and Ser to
Ala at position 68 or 105 (S68A and S105A, respectively) resulted in
lower levels of luciferase activity (60–65% of the WT level). The infec-
tivity of the RTmutant virus possessing a T58A or T107Amutation sig-
niﬁcantlydecreased to5–10%of theWT-virus level. The introductionof
the T131A, T216A, Y318A, T128A, Y146A or Y183A mutations com-
pletely abolished viral infectivity.
To evaluatewhetherHIV-1RTmutations affect RT activity,weused
theVpr-p66-WT fusionprotein (Fig. 1B),whichcanbeefﬁciently incor-
porated into virions [13–14]. The infectivity of T58A, T216AandY318A
waspartially restored from27%to55%of theWTinfectivitybycomple-
mentation with Vpr-p66-WT-V5 (Fig. 1C). In this complementation,
Vpr-p66-WT-V5 was efﬁciently packaged and processed (Fig. 1E).
The T107A mutant was not complemented by Vpr-p66-WT-V5. In
addition, the level of RNaseH-V5 in T107Awas signiﬁcantly decreased
comparedwith theWT virion, although the Vpr-p66-WT-V5 and p66-
WT-V5 levels in the T107A mutant were similar to WT levels. More-
over, the T131A, and Y183Amutations, which resulted in lower levels
of p66-WT-V5 and RNaseH-V5, were not complemented despite the
presence of Vpr-p66-WT-V5 (1.3–3.5% of the WT level). In the T128A
and Y146Amutants, themajority of Vpr-p66-WT-V5 in the virions re-
mained in the form of unprocessed fusion proteins, and thesemutants
exhibited defective viral replication (0.5–3.1% of theWT level). To fur-
ther examinewhether incorporating Gag–Pol-WT in trans restores the
infectivity of themutant viruses, Gag–Pol-complementedviruseswere
analyzed for infectivity using a luciferase assay (Fig. 1D). With the
exception of Y183A, mutant virus infectivity was partially rescued(26–75% of WT level) by this complementation. Of particular note, a
Y183A mutation incorporated into the WT Gag–Pol did not comple-
ment infectivity. This result was due to the p66-Y183A mutation
displaying some inhibitory potency, as indicated by Vpr-p66-Y183A
packaging into the WT virion (data not shown). We concluded that
the replication defects associated with the T58A, T216A and Y318A
mutants were due primarily to the disruption of RT activity, whereas
Thr-107, Thr-128, Thr-131, Tyr-146, and Tyr-183 may be involved in
Gag–Pol functions in HIV-1 replication.
3.2. Mutations of Thr-128 and Tyr-146 in RT abolish Gag–Pol
processing
To study whether the mutant RTs in the viral particles were
present in the p66 and p51 form of the RT, we used anti-RT serum
to detect virus-associated mutant RTs (Fig. 2A). The T128A, T131A
and Y146A mutations were not found in the p51 form of the RT.
Although all of the mutant RTs in the viral particles were detected
in the p66 form, T128A, T131A, Y146A, and Y318A mutants had
slightly reduced levels of the p66 form relative to the WT. These
mutants may be subject to PR-mediated degradation [15].
We next examined the proﬁles of particle-associated viral pro-
teins to identify possible Gag–Pol processing defects in these mu-
tants. The majority of the Gag-related proteins in the T128A and
Y146A mutant virions remained as unprocessed Pr55-Gag
(Fig. 2B). The defective Gag-processing phenotype of the T128A
and Y146A virions was apparent from the altered ratio of the
Pr55-Gag and p24 forms of the CA protein (Fig. 2C). Moreover,
the protein levels of HIV-1 protease and integrase were signiﬁ-
cantly reduced in the T128A and Y148A virions (Fig. 2D and E).
Thus, a single amino-acid substitution for Thr-128 or Tyr-148 in
the RT appeared to be responsible for the observed effects on
Gag–Pol processing.
3.3. Proteolytic cleavage of Gag–Pol was severely impaired at the
MA/CA and RT/IN sites in T128A and Y146A virions
To determine the defective sites of Gag–Pol processing in detail,
we incorporated several truncated Gag or Pol domains into HIV-1
virions in trans as fusion partners of Vpr (Fig. S1A). The proportion
of the processed products cleaved at the MA/CA and RT/IN sites
was signiﬁcantly reduced in T128A and Y146A mutants (Fig. S1B
and F). In contrast, the cleavage patterns for the SP1/NC, NC/SP2,
and SP2/P6 sites in T128A and Y146A mutants were similar to
those of the WT (Fig. S1C, D and E). These results suggest that pro-
tease-mediated Gag–Pol processing in T128A and Y146A virions
was partially affected, but these mutants retained protease
activity.
3.4. HIV-1 Gag–Pol processing is dependent on RT dimerization
To determinewhether RT dimerizationwas required for Gag–Pol
processing, we usedDTSSP (3,30-dithiobis(sulfosuccinimidylpropio-
nate)) to cross-link protein complexes present in the RT-V5-
expressing 293T cells. Only RT monomers were detected in the
non-cross-linked samples, with the exception of the Y146Amutant.
The addition of 0.2 mMDTSSP yielded cross-linked complexes of RT
homodimerswhen RT-WT-V5was expressed in 293T cells (Fig. 3). A
T131Amutation slightly reduced the level of RT homodimers in the
presence of DTSSP compared with the wild type. In contrast, an
abnormal patternwas observed in the Y146Amutant in the absence
or presence of DTSSP, suggesting that Y146A induced improper fold-
ing. Moreover, a T128A mutation resulted in very low levels of the
dimer under the same experimental conditions. T58A, Y183A and
T216A mutations, which resulted in normal Gag–Pol, retained RT
dimerization in the presence of DTSSP. These results suggest that
Fig. 1. Infectivity of HIV-1 RT mutants. (A) 293T cells were transfected with 0.1 lg of pMD.G-VSV-G and 0.1 lg of pNL43lucDenv containing the indicated RT mutations. The
293T cells were infected by pseudoviruses isolated from cell culture supernatants. The luciferase activity in the infected cells was measured 24 h postinfection. (B) An
illustration of the Vpr-p66-WT fusion protein including ten amino acids of the protease cleavage sequence at the Vpr-RT junction. (C, D) The 293T cells were transfected with
0.1 lg of wild type (WT) or each RT mutant pNL43lucDenv, 0.1 lg of pMD.G-VSV-G and 0.2 lg of pVpr-p66-WT-V5 (C) or pMDL-g/p-RRE (D). At 48 h post-transfection, the
293T cells were infected with the indicated pseudotyped viruses. Luciferase activities in the infected cells were measured 24 h postinfection. (E) Culture supernatants in
Fig. 1C were collected and subjected to Western immunoblot analysis using an anti-V5 antibody.
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bility that the T128A and Y146Amutations signiﬁcantly change the
conformation of Gag–Pol precursor, decreasing the accessibility of
the targets, cannot be excluded.
3.5. Detection of RT phoshorylation
Harada et al. have reported that HIV RT can be phosphorylated
in vitro by casein kinase 2 (CK2-alpha) [16]. We used Phos-tag
SDS–PAGE to determine whether CK2-alpha could phosphorylate
HIV-1 RT. A phos-tag binds to two Mn2+ ions and acts as a phos-
phate-binding molecule [17]. This complex is used for phosphate
afﬁnity SDS–PAGE, in which a mobility shift can be observed with
phosphorylated proteins. Recombinant His-RT was incubated with
recombinant CK2-alpha in the presence of ATP. As shown in
Fig. 4A, a shifted band of recombinant His-RT-WT was observed in
the presence of recombinant CK2-alpha in a dose-dependent man-
ner.Wenext examined thephosphorylation ofmutant RT. The phos-
phorylation levels of His-RT-T128A were similar to wild-type RT
(Fig. 4B). In the case of the His-RT-Y146Amutants, the phosphoryla-
tion levels were slightly reduced compared with wild-type levels.
Moreover, both the T128A and Y146A mutations in recombinant
His-RT severely decreased the phosphorylation levels. However, ashifted band corresponding to phosphorylated His-RT-T128A-
Y146A could be detected by using a large amount of recombinant
His-RT-T128A-Y146A in an in vitro kinase assay (Fig. 4C). To further
conﬁrm the phosphorylation of HA-RT-wild and its RT mutants
in vivo, HA-tagged RT or its mutants were expressed in 293T cells
and the cell lysates were immunoprecipitated with anti-HA anti-
body. The immune complexwas analyzed by Phos-tag, a probe used
to detect phosphorylated proteins (Fig. 4D).Wild-type RTwas phos-
phorylated in vivo. However, RT-T128A-Y146A signiﬁcantly re-
duced the phosphorylation levels. These results suggest that the
T128 andY146 residues, but not the RT phosphorylation sites,which
demonstrated a defect in RT dimerization, affected RT phosphoryla-
tion. RT phosphorylation may be required for its dimerization.
4. Discussion
Dunn et al. have reported that an L264S or E302Q mutation in
RT rendered the protein susceptible to degradation by PR within
virions [15]. In contrast, we identiﬁed here the critical amino acid
residues (T128 and Y146) that speciﬁcally affected RT dimerization
but had little effect on the stability of RT. To obtain structural in-
sights into the ﬁndings, we constructed a 3-D model of p51/p66
heterodimer of the wild-type (NL43) RT. The model shows that
Fig. 2. The effect of RT mutations on the processing of HIV-1 Gag–Pol. 293T cells were transfected with 0.2 lg of each RT mutant pNL4-3. At 48 h post-transfection, the
supernatants were harvested and subjected to Western-blot analysis. The Gag–Pol cleavage products were detected using anti-RT sera (A), an anti-CA antibody (B), an anti-
protease antibody (D) and an anti-integrase antibody (E). (C) The proportion of CA cleaved at the Pr55-Gag cleavage site was calculated from the integrated band intensities.
Fig. 3. Evaluation of RT dimerization. 293T cells were transfected with pLenti-p66-
V5 or the RT mutants. At 48 h post-transfection, the cells were lysed with CSK buffer
containing 0.5% NP-40. The cell lysates were incubated in either the absence or
presence of 0.2 mM DTSSP at room temperature for 20 min and analyzed by
Western blotting using an anti-V5 antibody.
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Thumb domain (Fig. S2A). Because helices are often critical in for-
mation of a stable core structure of a protein, the L264S or E302Q
mutations could critically inﬂuence proper folding and stability of
the Thumb domain. Such effects could affect RT dimerization be-
cause the thumb of the p51 subunit extensively interacts withthe RNase H domain. Simultaneously, the effects could increase
susceptibility of mutants to PR in a virion via exposure of improp-
erly folded domain. In contrast, the T128 and Y146 residues in p51
are positioned at the base of the b7–b8 loop, whose tip is embed-
ded in a small cleft of p66 surface and constituted of a direct inter-
action surface between p51 and p66 (Fig. S2B). Therefore
mutations at T128 and Y146 could inﬂuence orientation of the
b7–b8 loop and alter stability of the RT dimer. Meanwhile, the
mutations would not inﬂuence critically the stability of the RT, be-
cause the loop is positioned on protein surface. The failure of
detection of RT p51 subunit in these mutants (Fig. 2A) may suggest
that p66 dimerization is prerequisite for the processing. These
structural insights are well consistent with the present experimen-
tal ﬁndings. However, further studies will be required to clarify the
structure–function relationship with regard to the susceptibility of
RT to PR degradation.
The mutation of T128 or Y146 in RT impaired the protease-
mediated Gag–Pol processing. It is possible that substitutions in
RT signiﬁcantly change the conformation of the Gag–Pol precursor
and decrease the accessibility of the targets for the protease. How-
ever, the three-dimensional (3-D) model suggests that the T128
and Y146 residues are not positioned near the inherent cleavage
sites ﬂanking RT, i.e., N- and C-terminal end of the RT (Fig. S2). In
addition, reported electron microscopy studies suggest that Gag
precursor has a rodlike structure [18,19], by which the T128 and
Y146 residues are probably located far from the cleavage site and
other proteins. Therefore, the mutations at the T128 and Y146
are less likely to inﬂuence critically the protease accessibility into
the inherent cleavage sites of the Gag/Pol precursor protein,
although the inﬂuences are formally not ruled out at present. An
Fig. 4. The phosphorylation of recombinant RT in vitro. (A) Initially, 0.1 lg of recombinant His-RT-WT was incubated with 0.5 mM ATP in the absence or presence of 0.05 or
0.2 lg of recombinant His-CK2-alpha. The phosphorylation of recombinant His-RT was detected using Western immunoblot analysis after Phos-tag SDS–PAGE. The
phosphorylation of the recombinant His-RT was indicated as a shifted band. (B, C) 0.1 lg (B) or 1.0 lg (C) of indicated recombinant His-RT was incubated with 0.2 lg of
recombinant His-CK2-alpha in the absence or presence of 0.5 mM ATP. The phosphorylation of His-RT was detected as indicated in Fig. 4A. (D) 293T cells were transfected
with pcDNA-HA-RT or its RT mutants. At 48 h after transfection, the cells lysates were immunoprecipitated with anti-HA antibody and phosphorylated proteins were
detected using Phos-tag-Biotin and Streptavidin-conjugated HRP.
3376 H. Nishitsuji et al. / FEBS Letters 585 (2011) 3372–3377alternative possibility is that the mutations at the T128 and Y146
impaired the protease-mediated Gag–Pol processing via attenua-
tion of Gag/Pol dimerization for PR activation. Further study is nec-
essary to address each of these issues.
These observations are consistent with the hypothesis that anti-
viral drugs targeting RT might inhibit HIV-1 replication without
necessarily inhibiting the catalytic function of the RNA-dependent
DNA polymerase.
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